GT-19715

N/A

Report date: 2022/10/17 10:19:20

NME

Base Information

Drug NameGT-19715

Drug Alias NameGT-19630GT-19715GT-19630 (Free)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A modulatorsMyc proto-oncogene protein inhibitorsCereblon modulators +[4]

TargetsCereblonEukaryotic peptide chain release factor GTP-binding subunit ERF3AMyc proto-oncogene protein +[4]

Therapy Area/IndicationsSmall Cell Lung CarcinomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesSuzhou Koshine Biomedica Inc

China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung CarcinomaLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A